BRIEF-Silexion Therapeutics Announces Collaboration With Global Therapeutics Leader Catalent On Advanced Sirna Formulation Development & Clinical Manufacturing Activities

Reuters
23 Apr
BRIEF-Silexion <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces Collaboration With Global Therapeutics Leader <a href="https://laohu8.com/S/CTLT">Catalent</a> On Advanced Sirna Formulation Development & Clinical Manufacturing Activities

April 23 (Reuters) - Silexion Therapeutics Corp SLXN.O:

  • SILEXION THERAPEUTICS ANNOUNCES COLLABORATION WITH GLOBAL THERAPEUTICS LEADER CATALENT ON ADVANCED SIRNA FORMULATION DEVELOPMENT & CLINICAL MANUFACTURING ACTIVITIES

Source text: ID:nGNX1lWBsM

Further company coverage: SLXN.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10